Service agreement for the seahorse XFE96 analyzer
Ended Awarded
- Contract number
- 75N91023F00006
- Awardee
-
The Remi Group LLC UEI X458FNVQ1YX9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,755
Award facts
- Contract value 100% obligated
- $13,755.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a firm fixed-price service agreement to The Remi Group LLC for maintenance and support services on the Seahorse XFe96 Analyzer, a widely used instrument for cellular metabolic analysis in cancer research. This blanket purchase agreement (BPA) call, issued on August 1, 2023, carries a ceiling value of $13,755 and a completion date of July 31, 2024. The contract was awarded without a set-aside designation. The work will be performed in Rockville, Maryland, where the National Cancer Institute maintains significant research facilities.
The Remi Group LLC, a Charlotte, North Carolina-based for-profit Subchapter S corporation, specializes in equipment maintenance, repair, and technical support for scientific and medical instrumentation across federal agencies. The company brings substantial experience in maintaining complex analytical equipment for the National Institutes of Health and other federal entities. This engagement supports the National Cancer Institute's research infrastructure by ensuring reliable operation of the Seahorse XFe96 Analyzer, a critical tool for studying cellular metabolism in cancer biology research.
Quick answers
Who was awarded contract 75N91023F00006?
75N91023F00006 was awarded to The Remi Group LLC by National Cancer Institute (National Institutes of Health) on August 1, 2023.
How much is contract 75N91023F00006 worth?
The government has obligated $13,755 on 75N91023F00006.
Is contract 75N91023F00006 an order under another contract?
Yes. 75N91023F00006 is a BPA call under HHSN263201600136B, a blanket purchase agreement.
Was contract 75N91023F00006 competed?
The extent of competition for 75N91023F00006 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award